BET degrader exhibits lower antiproliferative activity than its inhibitor via EGR1 recruiting septins to promote E2F1-3 transcription in triple-negative breast cancer
Article in Pharmacological Research (August 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Pharmacological Research (August 2024)
Article in Journal of Pharmacology and Experimental Therapeutics (April 2024)
Article in Cancer Cell (February 2024)